These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 6576728

  • 21. [Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].
    Russell JA, Powles RL.
    Minerva Med; 1977 Oct 27; 68(51):3528-32. PubMed ID: 270618
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
    Eremeev VS, Rumyantsev AG, Akimova GV, Osipov SG, Kislyak NS, Bergolz VM.
    Neoplasma; 1981 Oct 27; 28(2):219-21. PubMed ID: 6942239
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chemoimmunotherapy of adult acute leukemia.
    McCredie KB, Bodey GP, Freireich EJ, Hester JP, Rodriguez V, Keating MJ.
    Cancer; 1981 Mar 15; 47(6):1256-61. PubMed ID: 6939477
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.
    Müller-Schmah C, Solari L, Weis R, Pfeifer D, Scheibenbogen C, Trepel M, May AM, Engelhardt R, Lübbert M.
    Ann Hematol; 2012 Jan 15; 91(1):27-32. PubMed ID: 21959947
    [Abstract] [Full Text] [Related]

  • 34. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM.
    Vopr Onkol; 1978 Jan 15; 24(11):16-24. PubMed ID: 283626
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunologic parameters of children with acute leucosis after cessation of polychemotherapy under repeated immunostimulation with intradermal B.C.G.
    Blau HJ, Eggers G, Kruse H, Schulz M, Grulich M.
    Arch Geschwulstforsch; 1982 Jan 15; 52(2):123-8. PubMed ID: 6954882
    [Abstract] [Full Text] [Related]

  • 37. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G, Amiel JL, Schwarsenberg L, Hyat M, Pouillart P, Schenider M, Cattan A, Jasmin C, Belpomme D, Schulmberger JR, De Vassal F, Musset M, Misset JL.
    Folia Clin Int (Barc); 1975 Mar 15; 25(3):131-51. PubMed ID: 1056311
    [No Abstract] [Full Text] [Related]

  • 38. Strength of binding between leukemic blasts and cytotoxic lymphocytes.
    Palucka AK, Waniewski J, Porwit A.
    Cytometry; 1996 Apr 01; 23(4):330-6. PubMed ID: 8900476
    [Abstract] [Full Text] [Related]

  • 39. Immunotherapy versus chemotherapy of acute myeloid leukemia: response to PHA, allogeneic lymphocytes, and leukemic myeloblasts of remission lymphocytes from leukemia patients.
    Reizenstein P, Ogier C, Sjögren AM.
    Recent Results Cancer Res; 1980 Apr 01; 75():29-36. PubMed ID: 6940210
    [Abstract] [Full Text] [Related]

  • 40. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G, Esin S, Favilli F, Pardini M, Bottai D, Maisetta G, Florio W, Campa M.
    Scand J Immunol; 2005 Dec 01; 62(6):498-506. PubMed ID: 16316416
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.